Page last updated: 2024-10-27

foscarnet and Coagulation Disorders, Blood

foscarnet has been researched along with Coagulation Disorders, Blood in 1 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Humphrey, RW1
O'Brien, TR1
Newcomb, FM1
Nishihara, H1
Wyvill, KM1
Ramos, GA1
Saville, MW1
Goedert, JJ1
Straus, SE1
Yarchoan, R1

Other Studies

1 other study available for foscarnet and Coagulation Disorders, Blood

ArticleYear
Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs.
    Blood, 1996, Jul-01, Volume: 88, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Base Sequence; Blood Coagulation Disord

1996